Demerger only viable option for Reckitt Benckiser and RB Pharmaceuticals

3rd August 2014

Suboxone nice to own when yielding easy profits but reinventing drug arm probably best undertaken by standalone management

Reckitt Benckiser‘s heroin substitute, Suboxone, has always been an oddity within a consumer goods portfolio stuffed with brands such as Cillit Bang, Dettol, Durex and Finish, but one can understand why a demerger has taken so long.

Read more at source article www.theguardian.com


Leave a Reply

Your email address will not be published.

42 + = 45

« back to posts